Taming the cytokine storm: small molecule inhibitors targeting IL-6/IL-6α receptor
Description
Given the increasing effectiveness of immune-based therapies, management of their associated toxicities is of utmost importance. Cytokine release syndrome (CRS), characterized by elevated levels of cytokine, poses a significant challenge following